Cargando…
Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
We have recently reported that interferon gamma receptor deficient (IFNγR−/−) allogeneic donor T cells result in significantly less graft-versus-host disease (GvHD) than wild-type (WT) T cells, while maintaining an anti-leukemia or graft-versus-leukemia (GvL) effect after allogeneic hematopoietic st...
Autores principales: | Choi, Jaebok, Cooper, Matthew L., Alahmari, Bader, Ritchey, Julie, Collins, Lynne, Holt, Matthew, DiPersio, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188578/ https://www.ncbi.nlm.nih.gov/pubmed/25289677 http://dx.doi.org/10.1371/journal.pone.0109799 |
Ejemplares similares
-
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
por: Ashami, Kidist, et al.
Publicado: (2018) -
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015) -
Antibody- and aptamer-strategies for GvHD prevention
por: Oelkrug, Christopher, et al.
Publicado: (2015) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022)